Vimarsana
Biggest News Aggregation in the World

Ancer Liver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Liver . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Liver Today - Breaking & Trending Today

New Trials in GI Cancers: Could Your Patient Benefit? - Vimarsana News

New Trials in GI Cancers: Could Your Patient Benefit?

Maybe one of your patients can join a new clinical trial in noncolorectal gastrointestinal cancer?

Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers - Vimarsana News

Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers

A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.

Fewer Than 1 in 4 Patients With HCV-Related HCC Get DAAs - Vimarsana News

Fewer Than 1 in 4 Patients With HCV-Related HCC Get DAAs

Early uncertainty about the safety of noninterferon antivirals in patients with liver cancer may have contributed to the slow acceptance of direct-acting antiviral agents in this population.

New Insights Into How Omega-3 Fatty Acids Improve NASH - Vimarsana News

New Insights Into How Omega-3 Fatty Acids Improve NASH

Omega-3 fatty acids downregulate expression of betacellulin in patients with NASH, providing a potential new avenue for prevention and treatment, a study has found.

MASLD, MASH Projected to Grow by 23% in the US Through 2050 - Vimarsana News

MASLD, MASH Projected to Grow by 23% in the US Through 2050

A mathematical model forecasts a steady increase in liver disease burden, including a near doubling of liver cancers and a more than twofold increase in liver transplants.